SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹10 Cr | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.57 Cr |
| Mar2022 | ₹7.09 Cr |
| Mar2021 | ₹6.83 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 3.18 | |
| Mar2024 | ₹10 Cr | 16.94 | |
| Mar2023 | ₹8.57 Cr | 20.87 | |
| Mar2022 | ₹7.09 Cr | 3.88 | |
| Mar2021 | ₹6.83 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,776.3 Cr | -4.1% | 4.2% | 134.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -4.1% |
4.2% |
134.1% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses